Global Gene Expression Analysis Reveals Dynamic and Developmental Stage–Dependent Enrichment of Lead-Induced Neurological Gene Alterations by Peterson, Samuel M. et al.
Environmental Health Perspectives  •  v o l u m e  119 | n u m b e r 5 | May 2011  615
Research
The heavy metal lead (Pb) is a well-studied 
toxi  cant known to cause a wide array of 
adverse health effects. The developing nervous 
system is especially susceptible to Pb-induced 
alterations, and the Centers for Disease 
Control and Prevention (CDC) currently 
recommends that primary prevention strate-
gies be implemented when a child’s blood Pb 
level (BLL) exceeds 10 μg/dL (CDC 2005). 
However, increasingly stringent regulatory 
actions have failed to limit exposures to a 
level documented as safe and without neuro-
logical impacts (Canfield et al. 2003; Min 
et al. 2007), including recent epidemiological 
studies that linked sub  interventional BLLs 
to decreased IQ (intelli  gence quotient) and 
attention span and increased behavioral prob-
lems and odds ratio for the development of 
attention deficit hyper  activity disorder (Eubig 
et al. 2010, Surkan et al. 2007). Moreover, 
although the mechanisms of Pb toxicity have 
been studied for many years, the molecular 
mechanisms under  lying the subtle neurologi-
cal impacts are not understood.
The developing nervous system is par-
ticularly susceptible to Pb toxicity because of 
increased levels of cell proliferation, migra-
tion, and differentiation and the complex-
ity of cell inter  actions (Rodier 1994, 2004). 
In addition, children absorb a greater per-
centage of ingested Pb, and circulating Pb 
has greater access to the brain because the 
blood–brain barrier is not yet fully established 
(Cory-Slechta and Schaumburg 2000; Leggett 
1993). Also, Pb can be released from mater-
nal bone stores and transferred to a devel-
oping fetus (Gardella 2001). As a result, Pb 
exposure can be initiated early in pre  natal 
development, and studies have indicated that 
umbilical BLLs ≤ 10 μg/dL are linked with 
deleterious effects on cognitive development 
(Gomaa et al. 2002). Thus, it is important 
to study Pb exposure in vivo during embryo-
genesis at a relevant concentration.
The zebrafish presents a complementary 
model to rodents to assess impacts of pre  natal 
chemical exposure. To specifically assess adverse 
effects associated with chemical exposure dur-
ing embryonic development in rodents, dam 
dosing and sacrifice are generally required. 
Alternatively, the zebrafish model has gained 
popularity in develop  mental and toxicological 
studies because of rapid ex utero embryonic 
development in which embryos can be dosed 
in a petri dish. Additionally, a near-  transparent 
chorion permits easy visualization of the devel-
oping organism throughout the entire embry-
onic period. Moreover, a single breeding pair 
can produce hundreds of embryos weekly, pro-
viding a large pool of individuals for experi-
mental testing. The application of the zebrafish 
model in developmental biology research has 
resulted in a plethora of background litera  ture, 
as well as the incorporation of the species into 
genetic and toxicology research. Moreover, a 
finished genome sequence and the homology 
between zebrafish and human genes permit 
translation of molecular mechanisms of tox-
icity observed in the zebrafish model system 
to humans (Barbazuk et al. 2000). Thus, the 
zebrafish provides an ideal model organism for 
defining molecular alterations associated with 
early develop  mental Pb exposure.
Although numerous studies have inves-
tigated Pb toxicity (see “Discussion” for 
examples), the molecular mechanisms under-
lying the subtle neurological effects on the 
developing nervous system are not thoroughly 
understood. The use of micro  array technology 
allows for the simultaneous measure  ment of 
the expression level of genes on a genome-
wide scale. When used with proper statisti-
cal approaches and genetic pathway analyses, 
a list of statistically signifi  cant, differentially 
expressed genes can be combined with an 
extensive database of gene and gene product 
inter  actions to provide a robust determina-
tion of commonly affected gene networks and 
pathways (Mattingly et al. 2009; Yang et al. 
2007). Based on the results of these calcula-
tions, the ability to predict and make hypothe-
ses about specific mechanisms of toxicity is 
strongly improved. In this study we aimed to 
identify key genes and regulatory networks 
perturbed by sub  lethal develop  mental Pb 
exposure. Our goal was to achieve enrichment 
of genes and molecular pathways associated 
with neuro  logi  cal develop  ment and disease in 
order to identify novel gene targets for future 
investigation into the specific genetic mecha-
nisms under  lying developmental Pb toxicity 
at sub  lethal doses. Using zebrafish ex utero 
development, we initiated exposure conditions 
immediately after fertilization to correspond to 
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Ba c k g r o u n d: The underlying genetic mechanisms specific to subtle neurological alterations 
  associated with environmental lead (Pb) exposures have not been clearly elucidated.
oBjectives: The goal of this study was to identify novel gene targets and the under  lying genetic 
mechanisms associated with developmental Pb neurotoxicity.
Me t h o d s : We first exposed zebrafish embryos to a range of Pb concentrations throughout early 
develop  ment to establish relative toxicity. Using the data from that experiment, we exposed another 
group of zebrafish embryos to a sub  lethal dose of Pb (100 ppb) immediately after fertilization through 
72 or 120 hr post  fertilization (hpf). Global gene expression was then analyzed for molecular pathways 
and gene ontology enrichment, and Western blot analysis was performed to investigate the translation 
of gene expression changes to protein levels. 
re s u l t s: After 72 hpf, we identified 231 probes representing 90 non  redundant genes with well-
established function or orthology to human genes as being altered by Pb exposure. This gene set was 
both confirmatory and novel in nature and was highly enriched for neurological development, func-
tion, and disease. Moreover, gene changes at this time point were correlated to altered protein levels. 
Alternatively, the gene set at 120 hpf did not share association with neuro  logical development.
co n c l u s i o n s: Global gene expression alterations associated with developmental Pb exposure 
were dynamic and dependent on developmental stage. Gene expression alterations at the 72-hpf 
time point were highly enriched with genes and molecular pathways associated with neurological 
develop  ment and disease. Moreover, we identified a number of novel targets for future exploration 
into their role in the genetic mechanisms underlying Pb-induced neurological alterations.
key w o r d s : Danio rerio, gene expression, genomics, lead, microarray, Pb, toxicogenomics, 
zebrafish. Environ Health Perspect 119:615–621 (2011).  doi:10.1289/ehp.1002590 [Online 
8 December 2010]Peterson et al.
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the mammalian in utero prenatal developmen-
tal period. We combined genome  wide expres-
sion analysis with pathway analysis to uncover 
novel genes of interest and to highlight criti-
cal time points in development. Further, we 
investigated translation of gene expression 
alterations to the protein level. 
Materials and Methods
Zebrafish husbandry. Zebrafish used in this 
study were of the wild-type AB strain; they 
were housed on a 14:10-hr light:dark cycle in 
a Z-Mod System (Aquatic Habitats, Apopka, 
FL) at 28°C. Adults were bred in spawning 
cages according to established protocols to 
obtain staged embryos (Westerfield 2000). 
For Pb treatment, embryos were collected at 
the 2- to 16-cell stage, washed, and sorted for 
experimental procedures. All protocols were 
approved by Purdue University’s Institutional 
Animal Care and Use Committee, with all fish 
treated humanely and with regard to allevia  tion 
of suffering.
Relative toxicity of Pb in zebrafish. We 
first performed an acute toxicity test to estab-
lish and confirm the relative toxicity of Pb to 
zebrafish and to determine an appropriate dose 
for gene expression analysis. Fifty embryos 
(considered as subsamples) were exposed to 
either control conditions (filtered aquarium 
water) or Pb treatment (Pb acetate; Sigma, St. 
Louis, MO) immediately after fertilization. Pb 
concentrations ranged from 1 to 100,000 ppb 
(micrograms per liter). Embryos were moni-
tored at 6-hr intervals for mortality, hatch-
ing time, and develop  mental malformations 
through 120 hr postfertilization (hpf). We 
conducted three replicate experiments (n = 3) 
and performed analysis of variance (ANOVA) 
with SAS software (version 9.2; SAS Institute 
Inc., Cary, NC) by develop  mental time point. 
Means were compared using the least signifi-
cant difference test at α = 0.05 when a signifi-
cant ANOVA was observed.
Global gene expression analysis. Based on 
the relative toxicity assessment, we selected 
100 ppb Pb as the experimental treatment for 
gene expression analysis. This experimental 
treatment represents a concentration that is 
well below the tested concentrations at which 
zebrafish exhibited mortality, alterations in 
hatching time, and gross morphological mal-
formations. Fifty embryos (considered as 
subsamples) were exposed to either control 
conditions or 100 ppb Pb as described above 
through 72 or 120 hpf. These two time points 
correlate, respectively, with a) the end of the 
embryonic phase and b) the initiation of com-
plex behaviors such as survival and hunting 
at which formation of the major brain struc-
tures is complete (Westerfield 2000). At the 
end of the treatment period, embryos were 
pooled, homogenized in Trizol (Invitrogen, 
Carlsbad, CA), and flash frozen in liquid 
nitrogen. Samples were stored at –80°C until 
RNA isolation was performed. Three biologi-
cal replicates were completed (n = 3) at both 
time points. Water samples were collected and 
analyzed for Pb concentration at an induc-
tively coupled plasma mass spectroscopy core 
facility, where measurement accuracy and sol-
ubility were confirmed.
Total RNA was isolated from embryos 
and converted to cDNA following established 
protocols (Peterson and Freeman 2009b). 
Microarray analysis was performed accord-
ing to Peterson and Freeman (2009a), with 
labeled samples hybridized onto the zebrafish 
385K expression microarray platform (Roche 
NimbleGen, Madison, WI) designed by 
Y. Zhou and L. Zon (Harvard Medical School 
and Children’s Hospital Boston, Boston, MA) 
using the one-color hybridization strategy.   
This platform contains 385,000 60-mer 
probes interrogating 37,157 targets with up 
to 12 probes per target. After hybridization, 
arrays were washed and scanned at 5 μm with 
a GenePix 4000B array scanner (Molecular 
Devices, Sunnyvale, CA).
Array image data were extracted using 
the NimbleScan software program (Roche 
NimbleGen). Fluorescence signal intensities 
were normalized using quantile normalization 
(Bolstad et al. 2003), and gene calls were gen-
erated using the Robust Multichip Average 
algorithm (Irizarry et al. 2003) following 
manufacturer recommendations.
Statistical processing. Further statistical 
processing of array data was performed with 
Array Star (version 3.0; DNASTAR, Inc., 
Madison, WI) and Ingenuity Pathway Analysis 
(IPA) software (version 8.0; Ingenuity Systems, 
Redwood City, CA) using a multi  tiered 
approach to determine a robust and repro-
ducible list of differentially expressed genes 
and to identify gene functions, pathways, and 
ontology groups enriched by this list. Criteria 
used to classify genes as being differentially 
expressed were adapted from recent recommen-
dations from the Microarray Quality Control 
Consortium (Guo et al. 2006; Shi et al. 2006). 
Two criteria were used to generate a list of 
significantly and consistently altered genes: 
a) genes consistently expressed (Student’s t-test, 
p ≤ 0.1) and substantially altered at a mean 
absolute log2 expression ratio of at least 0.585 
(50% increase or decrease in expression); and 
b) genes consistently altered by a minimum 
absolute log2 expression ratio of 0.585 in all 
three replicates. Differently expressed gene sets 
were imported into IPA to establish gene clas-
sifications and gene enrichment categories.
Quantitative polymerase chain reaction 
(qPCR) comparison. We compared micro-
array data with qPCR on a set of selected genes. 
Probes specific for these genes were designed 
using the Primer3 website (SourceForge 2010) 
as described by Rozen and Skaletsky (2000) [see 
Supplemental Material, Table 1 (doi:10.1289/
ehp.1002590)]. qPCR analysis was performed 
on a Stratagene MX3000P qPCR system 
(Agilent, La Jolla, CA) using iQ SYBR Green 
Supermix kit (Bio-Rad, Hercules, CA) accord-
ing to the manufacturer’s recommendations. 
The cycling parameters included a 3-min incu-
bation phase at 95°C, 40 cycles of 95°C for 
10 sec, 60°C for 30 sec, and 72°C for 30 sec, 
and a dissociation curve to check for non  specific 
amplification. Efficiency and specificity were 
checked with melting and dilution curve analy-
sis and no-template controls. Threshold values 
were calculated, and individual gene expression 
was normalized to glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH).
Protein level analysis. We performed 
Western blot analysis to determine if gene 
expression alterations were correlated to protein 
levels of altered genes. Protein was isolated from 
whole embryos exposed to control treatment or 
to 100 ppb Pb using Cell Lytic MT Mammalian 
Tissue Lysis/Reagent (Sigma). Protein isolates 
were separated using sodium dodecyl sulfate–
polyacrylamide gel electrophoresis and trans-
ferred to a polyvinyl difluoride membrane 
(Bio-Rad). We obtained primary anti  bodies for 
metallo  thionein 2 (MT2; ab12228), FRY-like 
(FRYL; ab95065), and GAPDH (ab8245) from 
Abcam (Cambridge, MA); for reelin (RELN; 
anti-RELN clone 142) from Millipore (Billerica, 
MA); and for mitogen-activated protein kinase 8 
(MAPK8; anti-MAPK-8 CT) from AnaSpec 
(Fremont, CA). After incubation with appropri-
ate horse  radish peroxidase–conjugated secondary 
anti  bodies, protein bands were visualized with 
the Immun-Star WesternC Chemiluminescence 
Kit on a ChemiDoc XRS+ imager (both 
from Bio-Rad). We used Image Lab Software 
(Bio-Rad) to calculate relative quantification 
of three biological replicates after normalizing 
proteins of interest to GAPDH. An unpaired 
Student’s t-test was used to determine significant 
alterations in protein levels.
Results
Relative toxicity of Pb in zebrafish. We per-
formed an acute toxicity test through 120 hpf 
to characterize the general response of zebrafish 
embryos to develop  mental Pb exposure, with 
specific end points of survival and hatching 
rate. We observed a dose response in mor-
tality rates, with higher concentrations dis-
playing greater levels of embryo mortality and 
with deaths occurring closer to the onset of 
the experi  ment (Figure 1). Embryos treated 
with the highest Pb concentrations (100,000 
and 50,000 ppb) had a survival percentage 
that began to differ from control (p ≤ 0.05) at 
54 and 96 hpf, respectively, and reached near 
or complete mortality before the end of the 
experiment. All Pb concentrations ≥ 5,000 ppb 
reached a level of significant difference in   
mortality by 120 hpf (p ≤ 0.05; Figure 1).Global gene expression alterations of Pb exposure
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To obtain an estimate of hatching delay, 
we compared the average time it took treat-
ment groups to obtain a specific level of 
hatching (Figure 2). We excluded data from 
the analysis when levels of increased mortal-
ity interfered with interpretation (i.e., when 
mortality rates were different from controls at 
time points reported above). Embryos treated 
with all Pb concentrations ≥ 5,000 ppb 
demon  strated a significant delay in hatching 
compared with controls (p ≤ 0.05). Control 
embryos obtained a 50% hatching rate by a 
mean time of 34 hpf, whereas the embryos 
treated with 5,000 and 10,000 ppb Pb were 
delayed and did not reach a 50% hatching 
rate until the mean times of 48 and 56 hpf, 
respectively. We observed more severe delays 
in the highest two concentrations, 50,000 ppb 
and 100,000 ppb, with mean hatching times 
of 72 and 81 hpf, respectively.
Global gene expression analysis at 72 hpf. 
From the results of the relative toxicity 
assay, we chose an exposure concentration of 
100 ppb for global gene expression analysis to 
represent a concentration well below one that 
induced overt toxicity. Global gene expression 
analysis performed on zebrafish embryos at 
72 hpf resulted in a scatter plot with an R2 cor-
relation of 0.9813 [see Supplemental Material, 
Figure 1A (doi:10.1289/ehp.1002590)]. 
We observed a total of 231 altered probes at 
this time point (see Supplemental Material, 
Table 2). After accounting for redundant 
probes that targeted identical genes and remov-
ing probes targeting hypothetical proteins 
without substantial function or ontology infor-
mation, significant annotation and network 
information was available for 90 genes ortholo-
gous to human genes with established func-
tions. Gene ontology analysis performed with 
IPA software classified genes into non  exclusive 
categories (i.e., genes can belong to more than 
one related or distinct category). This list of 
genes was highly enriched for genetic dis  orders 
and neurological disease, as well as several 
molecular functions and physiological systems 
(Table 1). Specifically, a number of genes 
were associated with one or more genetic or 
neurological disorders, including Alzheimer’s 
disease, non-insulin-dependent diabetes, bipolar   
disorder, and Parkinson’s disease (Table 1). 
We observed significant enrichment with 
55 of the 90 genes involved in neurological 
develop  ment, function, and disease with spe-
cific areas affected, including synaptic transmis-
sion, long-term potentiation (LTP), guidance 
of axons, and branching of neurites (Table 2, 
Figure 3A,B). Overall, this gene list included 
targets that were both confirmatory, represent-
ing genes previously identified to be associated 
with Pb toxicity, and novel in nature.
Global gene expression analysis at 120 hpf. 
The expression patterns of Pb-treated and 
control embryos differed less from each other 
at 120 hpf. The R2 correlation of the result-
ing scatter plot was 0.9918, with 82 probes 
being classified as significantly altered [see 
Supplemental Material, Figure 1B, Table 3 
(doi:10.1289/ehp.1002590)]. Of these 
82 probes, significant annotation and func-
tional information was available for 30 non-
redundant genes. The gene list for this 
developmental time point did not share the 
same association as the 72 hpf set and dis-
played some association with renal, urological, 
and hematological disorders, as well as cancer, 
lipid metabolism, tissue develop  ment, and 
cardio  vascular system development and func-
tion (see Supplemental Material, Table 4).
Figure 1. Acute toxicity test for mortality in zebrafish embryos exposed to a range of Pb concentrations for 
120 hpf and monitored for severe malformations and death. The survival rate is presented as the percentage 
(mean ± SD) of embryos surviving at each time point, determined using three replicates of 50 embryos each. 
*p ≤ 0.05, and **p ≤ 0.0001 compared with controls.
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Figure 2. Acute toxicity test for hatching rate (percentage of surviving embryos hatched) alterations in 
zebrafish embryos after exposure to various concentrations of Pb. Values represent (mean ± SD) time 
required (hpf) to reach levels of hatching (n = 3, with 50 subsamples per replicate).
aData were excluded because analysis of this end point was confounded by concurrent mortality rates in the treatment 
group. *p ≤ 0.05 compared with controls. 
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Table 1. Gene ontology of altered genes at 72 hpf.
Function category p-Valuea
No. of 
genesb
Genetic disorder or neurological disease
Alzheimer’s disease 3.05E–05 16
Non-insulin-dependent diabetes 6.19E–05 20
Progressive motor neuropathy 1.45E–02 13
Coronary artery disease 2.34E–03 15
Neurodegenerative disorder 1.64E–05 17
Parkinson’s disease 6.28E–03 9
Cellular development
Developmental processes of axons 4.78E–02 5
Shape change of neurons 6.81E–03 2
Cell-to-cell signaling interaction
Long-term depression of cells 6.34E–04 5
Synaptic transmission 8.60E–04 7
Cellular assembly and organization
Density of synaptic vesicles 1.58E–04 2
Quantity of synaptic vesicles 9.34E–04 2
Growth of neurites 3.11E–03 7
Morphogenesis of neurites 3.60E–03 4
Cell morphology
Morphogenesis of dendrites 4.08E–03 3
Branching of neurites 5.73E–03 3
Depolarization 4.27E–03 3
Nervous system development and function
Neurological processes of axons 1.12E–03 5
Guidance of axons 2.55E–02 2
LTP 6.34E–04 5
LTP, long-term potentiation.
aDerived from the likelihood of observing the degree of 
enrichment in a gene set of a given size by chance alone. 
bClassified as being differentially expressed that relate to 
the specified function category; a gene may be present 
in more than one category.Peterson et al.
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Comparison of microarray and qPCR data. 
We compared micro  array data with qPCR on 
a subset of genes. Probes selected comprised 
genes altered at 72 hpf or at 120 hpf, with 
most genes relating to neuro  logical develop-
ment [see Supplemental Material, Table 1 
(doi:10.1289/ehp.1002590)]. We observed 
a high level of agreement between the genes 
determined to be altered according to micro-
array data and the qPCR analysis (assessed by 
two-sided t-test, p ≤ 0.05).
Protein level analysis. Using Western 
blot analysis, we measured relative changes 
in the protein levels of MT2, FRYL, RELN, 
and MAPK8. Significant alterations were 
present in MT2, RELN, and FRYL levels   
in Pb-treated samples, whereas MAPK8 
appeared to be unchanged (Figure 4). The 
levels of MT2 protein increased to > 600% of 
control (p = 0.006). The antibody for RELN 
recognized multiple bands that correspond 
to the full-length protein as well as expected 
processed fragments. The levels of the unpro-
cessed form were increased to 309% of control 
in the treated samples (p = 0.0425). FRYL pro-
tein was markedly decreased, as evidenced by 
two bands representing products of similar size 
(larger product: 63% of control, p = 0.047; 
smaller product: 57% of control, p = 0.016; 
combined: 60.2% of control, p = 0.020). 
MAPK8 protein levels did not significantly 
change with Pb treatment (p = 0.53).
Discussion
In the present study, we characterized gene 
expression alterations induced by Pb expo-
sure at two early developmental time points 
in order to provide a framework for assessing 
the biological pathways and functions that 
are perturbed and susceptible to a sub  lethal 
dose of Pb. Based on established research and 
epidemiological studies, we hypothesized that 
the developing nervous system would be the 
most sensitive to Pb-induced alterations and 
that genes relating to these processes would 
be among the first to be altered. At higher 
Pb doses, pathways that are altered by lower 
doses of Pb are likely to be indistinguishable in 
the multitude of drastic gene alterations that 
accompany more general toxic responses (e.g., 
oxidative stress, heat-shock protein–associated 
expression, apoptosis). Furthermore, expo-
sures to high doses of Pb can result in myriad 
effects, damaging most organ systems. The 
interpretation of neurologically based effects 
would be compromised by using a dose in 
which other effects are prominently observed.
The complex binding dynamics and 
absorption proprieties of Pb do not permit 
easy approximation of the zebrafish develop-
mental dose equivalent to a child with a BLL 
in the range of interest (1–10 μg/dL, equiva-
lent to 10–100 ppb). To accomplish this end 
and to approximate a relevant dose, we first 
performed a relative toxicity assay to charac-
terize the general response of the embryos 
to a range of Pb concentrations. Each group 
of embryos treated with concentrations 
≥ 5,000 ppb demon  strated a significant delay 
in hatching and increased mortality. The high-
est concentrations elicited almost complete 
mortality and interfered with analysis of hatch-
ing rates at later developmental time points. 
As a result of these data, we chose an exposure 
concentration of 100 ppb (0.48 μM, equiva-
lent to 10 μg/dL). Embryos treated at this 
concentration were consistently similar to con-
trols at all developmental time points analyzed 
and did not elicit any observable toxicity.
The use of in vivo and in vitro models has 
demonstrated a number of structural and func-
tional neuro  toxic consequences of Pb exposure 
and provides support for data from epidemio-
logical studies (Min et al. 2007). However, 
the molecu  lar mechanisms under  lying the 
subtle neurological alterations associated with 
Table 2. Neurological genes altered at 72 hpf.
Symbol Gene namea Log2 expression ratio
ABI1 abl-interactor 1 –0.84
ANK2 ankyrin 2, neuronal –0.67
ANO3 anoctamin 3 –0.90
AP3D1 adaptor-related protein complex 3, delta 1 subunit –0.97
BAT2 HLA-B associated transcript 2 –1.74
CACNA1A calcium channel, voltage-dependent, P/Q type, alpha 1A subunit –1.05
CACNA1C calcium channel, voltage-dependent, L type, alpha 1C subunit –1.18
CELSR3 cadherin, EGF LAG seven-pass G-type receptor 3 (flamingo homolog, Drosophila) –1.45
COL11A2 collagen, type XI, alpha 2 –1.99
CSF1R colony stimulating factor 1 receptor 0.90
CTSL2 cathepsin L2 0.61
ENPP5 ectonucleotide pyrophosphatase/phosphodiesterase 5 –0.74
ERAP1 endoplasmic reticulum aminopeptidase 1 0.59
FAT1 FAT tumor suppressor homolog 1 (Drosophila) –1.00
FRYL FRY-like –1.62
GABRR2 gamma-aminobutyric acid (GABA) receptor, rho 2 0.66
GRIA3 glutamate receptor, ionotrophic, AMPA 3 –0.75
GRM3 glutamate receptor, metabotropic 3 –0.70
HEATR5B HEAT repeat containing 5B –0.91
HIVEP2 human immunodeficiency virus type I enhancer binding protein 2 –0.84
IGSF9 immunoglobulin superfamily, member 9 –0.69
KCNH8 potassium voltage-gated channel, subfamily H (eag-related), member 8 –0.72
KIF1A kinesin family member 1A –0.99
KIF1B kinesin family member 1B –1.17
LAMA1 laminin, alpha 1 –0.81
LRP1 low density lipoprotein receptor-related protein 1 –1.54
LRP1B low density lipoprotein receptor-related protein 1B –0.77
MACF1 microtubule-actin crosslinking factor 1 –1.21
MADD MAP-kinase activating death domain –0.89
MAPK8 mitogen-activated protein kinase 8 –0.87
MBD5 methyl-CpG binding domain protein 5 –1.04
MLL3 myeloid/lymphoid or mixed-lineage leukemia 3 –0.69
MOBP myelin-associated oligodendrocyte basic protein –0.66
MT2A metallothionein 2A 0.87
MYCBP2 MYC binding protein 2  –1.06
NAV3 neuron navigator 3 –0.77
NCOR2 nuclear receptor co-repressor 2 –1.21
NRXN2 neurexin 2 –1.29
NTRK2 neurotrophic tyrosine kinase, receptor, type 2 –0.80
OSBPL6 oxysterol binding protein-like 6 –0.62
PCLO piccolo (presynaptic cytomatrix protein) –1.01
PDE4DIP phosphodiesterase 4D interacting protein –1.94
PICALM phosphatidylinositol binding clathrin assembly protein –0.78
POU2F1 POU class 2 homeobox 1 –0.78
RELN reelin –1.32
ROBO2 roundabout, axon guidance receptor, homolog 2 (Drosophila) –1.36
RYR3 ryanodine receptor 3 –1.34
SHANK1 SH3 and multiple ankyrin repeat domains –0.94
SNX26 sorting nexin 26 –1.02
SREBF1 sterol regulatory element binding transcription factor 1 –0.97
SYNE1 spectrin repeat containing, nuclear envelope 1 –0.67
UBR4 ubiquitin protein ligase E3 component n-recognin 4 –1.31
VPS13B vacuolar protein sorting 13 homolog B (yeast) –0.61
WDFY3 WD repeat and FYVE domain containing 3 –1.22
WDR7 WD repeat domain 7 –1.09
aFrom National Center for Biotechnology Information (2010). Global gene expression alterations of Pb exposure
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environmental Pb exposure during develop-
ment are not completely understood. In the 
present study, we used micro  array technol-
ogy to identify gene targets and unravel the 
under  lying molecular mecha  nisms of neuro-
developmental alterations associated with 
sub  lethal Pb exposure in an in vivo system 
during early development. The molecular 
targets altered at 72 hpf included genes that 
were both confirmatory and novel in nature. 
Confirmatory genes previously reported as hav-
ing altered expression or gene product func-
tion after Pb exposure and that are involved 
in neurological development, function, or dis-
ease included LRP1 (low density lipoprotein 
receptor-related protein 1) (Behl et al. 2009), 
MAPK8 (Posser et al. 2007), CSF1R (colony 
stimulating factor 1 receptor) (Kowolenko 
et al. 1989), GRM3 (glutamate receptor, 
metabotropic 3) (Xu et al. 2007), MT2A 
(metallo  thionein 2A) (Wang et al. 2009), and 
POU2F1 (POU class 2 homeo  box 1) (Glahn 
et al. 2009). Moreover, the list of genes altered 
at 72 hpf related not only to general nervous 
system development but specifically to distinct 
functions previously reported as perturbed 
by Pb exposure in which established specific 
molecular targets are lacking. These novel gene 
targets provide additional insight into the spe-
cific molecular mechanisms associated with 
established Pb-induced functional alterations, 
including genes related to neuronal onto  genesis 
and synapse formation and function.
Neuronal ontogenesis has been reported to 
be perturbed by Pb exposure through a reduc-
tion in neuron growth, axon and dendrite 
branching, and altered expression of neural 
cell adhesion molecules (N-CAMs; Figure 3A) 
(Cory-Slechta and Schaumburg 2000). The 
most notable of the altered genes in this experi-
ment that are associated with these functions 
include RELN, a gene with multiple functions 
throughout early nervous system development, 
including a role in activating a signal cascade for 
regulating neuronal migration (Jossin 2004), 
and ROBO2 [roundabout, axon guidance 
receptor, homolog 2 (Drosophila)], a gene that 
activates a repulsive guidance signal for neurons 
(López-Bendito et al. 2007). Additional genes 
of note that have been implicated in the growth 
and guidance of axons and that we observed 
to have altered expression at 72 hpf include 
FRYL, LAMA1 (laminin, alpha 1), MYCBP2 
(MYC binding protein 2), and NAV3 (neuron 
navigator 3). Furthermore, the altered behavior 
and expression of N-CAMs are associated with 
Pb exposure. The disruption of these glyco-
proteins has been implicated as a contributor 
to the altered brain morpho  genesis observed in 
animal models, because the N-CAMs play a 
key role in cell–cell inter  actions such as neurite 
outgrowth and regulation of synaptic contacts 
(Shi et al. 2004). Specifically, IGSF9 (immuno-
globulin superfamily, member 9), a member 
of the N-CAM family, demonstrated altered 
expression at 72 hpf in the Pb-exposed embryos 
in the present study.
Synapse formation and the regulation 
of LTP are established phenotypic conse-
quences of Pb exposure, and a large number 
of genes linked to these processes were altered 
at 72 hpf (Figure 3B) (Gilbert et al. 1999). 
These targets included genes for multiple 
neuro  transmitter receptors (GRIA3, GRM3, 
and GABRR2), PCLO [piccolo (pre  synaptic 
cytomatrix protein)], and NTRK2 (neuro-
trophic tyrosine kinase, receptor, type 2). Pb 
has been shown to interfere with both the 
Figure 3. Schematic representation of altered neurological gene enrichment at 72 hpf after exposure to 100 ppb Pb, enriched with genes related to neurological 
function. All gene ontology categories were gathered from the Database for Annotation, Visualization and Integrated Discovery (DAVID) Bioinformatics Resources 
6.7 (Huang et al. 2009a, 2009b), with the exception of FRYL and NAV3, which were categorized from Emoto et al. (2004) and Maes et al. (2002), respectively. Among 
the set of 90 altered genes, enrichment was seen in genes relating to neurite projections (A) and synapse function (B). See Table 2 for full gene names. 
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Figure 4. Protein levels of four genes with altered expression at 72 hpf (MT2, FRYL, RELN, and MAPK8) 
as determined by Western blot analysis (A). Differences in protein levels of genes of interest in zebrafish 
embryos following exposure to 100 ppb Pb were compared with controls after being normalized to GAPDH 
(B). All blots are representative of results of three biological replicates. Protein levels of MT2 (B), FRYL 
(C), and RELN (D) were all altered in the Pb-treated embryos, whereas MAPK8 (E) did not demonstrate a 
significant alteration.
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glutamate and GABAergic neuro  transmitter 
systems that play important roles in maintain-
ing synaptic plasticity and the formation of 
LTP (Braga et al. 1999). Further association 
with genes relating to LTP can be seen with 
the alterations in gene expression observed in 
PCLO, NTRK2, and the previously discussed 
IGSF9 and RELN. Overall, multiple genes 
altered after Pb exposure in this study are 
associated with functions previously indicated 
to be perturbed by Pb exposure but for which 
molecular targets are currently lacking.
To investigate whether alterations of gene 
expression identified in the present study trans-
late to the protein level, we performed Western 
blot analysis to meas  ure the relative protein lev-
els of four molecular targets with altered gene 
expression: MT2, RELN, FRYL, and MAPK8. 
The most striking result came from the dra-
matic increase in MT2 levels. The increase in 
the full-length RELN protein is also interest-
ing in that levels of this unprocessed form are 
generally extremely low in vivo, and processed 
forms are pre  dominantly observed (Tissir and 
Goffinet 2003). The reason for the accumula-
tion of unprocessed protein is not known, but 
we hypothesize it to be a result of Pb interfer-
ing with proper protein cleavage. The FRYL 
protein products we detected in the present 
study are shorter than the human protein, but 
this protein has yet to be charac  terized in the 
zebrafish. Regardless, we observed a decrease in 
the relative amounts of FRYL in the Pb-treated 
embryos compared with controls. Further 
research is needed to determine the exact struc-
ture and functional role of these products. 
Overall, we observed altered protein levels for 
three of the four molecular targets, indicating 
that gene expression alterations are being trans-
lated to the protein level.
Interestingly, at the later time point ana-
lyzed (120 hpf), we did not observe an asso-
ciation with neurological development, and 
overall, fewer genes had altered expression. 
One gene of interest, POMC (pro  opio  melano-
cortin), has previously been associated with 
low-level Pb exposure (Rosen and Polakiewicz 
1989). In addition, we observed no overlap 
between genes with altered expression at the 
two developmental time points. Of note, by 
120 hpf, many of the zebrafish organ systems, 
including the nervous system, have progressed 
through much of organo  genesis. The high 
degree of rapidly dividing, differentiating, and 
migrating cells involved in the key stages of 
brain development have largely stabilized by 
120 hpf (Mueller and Wullimann 2005). It is 
likely that these processes account for the high 
degree of Pb-induced susceptibility responsible 
for the alterations observed at 72 hpf, support-
ing the notion that toxico  genomic responses 
are develop  mental stage–dependent and repre-
sent a snapshot of the dynamic developmental 
processes occurring at specific time points.
Overall, in the present study we a) iden-
tified a number of novel genetic targets 
associated with develop  mental exposure to 
a sub  lethal Pb concentration, b) identified 
enrichment of genes associated specifically 
with neurite growth and inhibition of LTP 
and synapse formation at 72 hpf, and c) found 
that gene expression changes are being trans-
lated to the protein level. Alternatively, we 
did not observe an association between per-
turbed genes and neuro  logical function at 
120 hpf. We found a lack of overlap between 
the neuro  logi  cal genes altered in our study 
compared with other genomic studies of Pb 
toxicity (Bouton et al. 2001; Yang et al. 2007). 
Differences may be attributed to dis  similarity 
in experi  mental design, including experimental 
systems, dose, and specific developmental time 
points analyzed. Although at the present time 
it is unclear whether the altered gene expres-
sion resulted in permanent alterations, the 
gene targets and molecular pathways identified 
at 72 hpf support a molecular basis for altera-
tions of neurite growth and synapse formation 
and function that have been observed in previ-
ous studies. Future studies will focus on fur-
ther elucidating and correlating the molecular 
basis of pheno  typic alterations associated with 
sub  lethal doses of Pb exposure.
Conclusion
We exposed zebrafish embryos to a sub  lethal 
dose of Pb and analyzed global transcriptional 
alterations at two developmental time points. 
Only during the earlier time point were genes 
relating to neuro  development and func-
tion selectively altered. The differing results 
acquired at the two develop  mental time points 
highlight the importance of careful assess-
ment of exposure duration and of specific time 
points in develop  mental toxicology studies, 
because gene expression is dynamic through-
out develop  ment and represents a snapshot of 
the molecular processes representative of that 
develop  mental stage.
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